Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AsfiledCriticalH Lundbeck As
Priority claimed from PCT/EP2014/078475external-prioritypatent/WO2015091805A1/en
Publication of MA39118A1publicationCriticalpatent/MA39118A1/en
Publication of MA39118B1publicationCriticalpatent/MA39118B1/en
La présente invention concerne des quinazoline-thf-amines utilisées en tant qu'inhibiteurs de la pde1 ainsi que leur utilisation en tant que médicament, en particulier pour le traitement de troubles neurodégénératifs et de troubles psychiatriques.The present invention relates to quinazoline-thfamines used as inhibitors of pde1 as well as their use as a medicament, particularly for the treatment of neurodegenerative disorders and psychiatric disorders.
MA39118A2013-12-192014-12-18
Quinazolin-thf-amines used as inhibitors of pde1
MA39118B1
(en)
N- [4- (quinolin-4-yloxy) cyclohexyl (methyl)] (hetero) arylcarboxamides for use as androgen receptor antagonists, their production and their use as medicaments